Aluminum granuloma in a child secondary to DTaP-IPV vaccination: A case report

Carter K. Haag, Elizabeth Dacey, Nick Hamilton, Kevin White

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Reports detailing the acute formation of aluminum granulomas, which can cause persistent, intensely pruritic nodules secondary to the administration of aluminum-containing vaccines, are infrequently described in medical literature. To our knowledge, this is the first report describing the development of an aluminum granuloma causing a persistent, pruritic nodule at the injection site following the administration of the DTaP-IPV vaccine. We present the case of a 6-year-old girl who developed a severely pruritic subcutaneous nodule on her anterior right thigh at the injection site three weeks after the administration of the aluminum-containing DTaP-IPV (Kinrix) vaccine. The nodule was eventually excised 14 months after its initial appearance, after which her symptoms resolved. Histologic inspection demonstrated a dense, deep dermal and subcutaneous nodular mixed infiltrate of lymphocytes, histiocytes, and eosinophils, with germinal center formation. The bluish, amphophilic granular cytoplasm found in most of the histiocytes is a characteristic feature of “aluminum granulomas.” This adverse reaction should be considered in any patient presenting with similar findings in the weeks following a DTaP-IPV vaccination or other aluminum-containing vaccines. Furthermore, the self-limiting tendency of these nodules should not preclude affected patients from any future vaccinations, though vaccines without aluminum should be preferentially selected when possible.

Original languageEnglish (US)
JournalPediatric Dermatology
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Granuloma
Aluminum
Vaccination
Vaccines
Histiocytes
Diphtheria-Tetanus-acellular Pertussis Vaccines
Injections
Germinal Center
Thigh
Eosinophils
Cytoplasm
Lymphocytes
Skin

Keywords

  • aluminum granuloma
  • dermatopathology
  • pediatric dermatology
  • subcutaneous nodule
  • vaccine site reactions
  • vaccines

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Dermatology

Cite this

Aluminum granuloma in a child secondary to DTaP-IPV vaccination : A case report. / Haag, Carter K.; Dacey, Elizabeth; Hamilton, Nick; White, Kevin.

In: Pediatric Dermatology, 01.01.2018.

Research output: Contribution to journalArticle

@article{7a616f214145482a978cfe9ff317aa74,
title = "Aluminum granuloma in a child secondary to DTaP-IPV vaccination: A case report",
abstract = "Reports detailing the acute formation of aluminum granulomas, which can cause persistent, intensely pruritic nodules secondary to the administration of aluminum-containing vaccines, are infrequently described in medical literature. To our knowledge, this is the first report describing the development of an aluminum granuloma causing a persistent, pruritic nodule at the injection site following the administration of the DTaP-IPV vaccine. We present the case of a 6-year-old girl who developed a severely pruritic subcutaneous nodule on her anterior right thigh at the injection site three weeks after the administration of the aluminum-containing DTaP-IPV (Kinrix) vaccine. The nodule was eventually excised 14 months after its initial appearance, after which her symptoms resolved. Histologic inspection demonstrated a dense, deep dermal and subcutaneous nodular mixed infiltrate of lymphocytes, histiocytes, and eosinophils, with germinal center formation. The bluish, amphophilic granular cytoplasm found in most of the histiocytes is a characteristic feature of “aluminum granulomas.” This adverse reaction should be considered in any patient presenting with similar findings in the weeks following a DTaP-IPV vaccination or other aluminum-containing vaccines. Furthermore, the self-limiting tendency of these nodules should not preclude affected patients from any future vaccinations, though vaccines without aluminum should be preferentially selected when possible.",
keywords = "aluminum granuloma, dermatopathology, pediatric dermatology, subcutaneous nodule, vaccine site reactions, vaccines",
author = "Haag, {Carter K.} and Elizabeth Dacey and Nick Hamilton and Kevin White",
year = "2018",
month = "1",
day = "1",
doi = "10.1111/pde.13732",
language = "English (US)",
journal = "Pediatric Dermatology",
issn = "0736-8046",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Aluminum granuloma in a child secondary to DTaP-IPV vaccination

T2 - A case report

AU - Haag, Carter K.

AU - Dacey, Elizabeth

AU - Hamilton, Nick

AU - White, Kevin

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Reports detailing the acute formation of aluminum granulomas, which can cause persistent, intensely pruritic nodules secondary to the administration of aluminum-containing vaccines, are infrequently described in medical literature. To our knowledge, this is the first report describing the development of an aluminum granuloma causing a persistent, pruritic nodule at the injection site following the administration of the DTaP-IPV vaccine. We present the case of a 6-year-old girl who developed a severely pruritic subcutaneous nodule on her anterior right thigh at the injection site three weeks after the administration of the aluminum-containing DTaP-IPV (Kinrix) vaccine. The nodule was eventually excised 14 months after its initial appearance, after which her symptoms resolved. Histologic inspection demonstrated a dense, deep dermal and subcutaneous nodular mixed infiltrate of lymphocytes, histiocytes, and eosinophils, with germinal center formation. The bluish, amphophilic granular cytoplasm found in most of the histiocytes is a characteristic feature of “aluminum granulomas.” This adverse reaction should be considered in any patient presenting with similar findings in the weeks following a DTaP-IPV vaccination or other aluminum-containing vaccines. Furthermore, the self-limiting tendency of these nodules should not preclude affected patients from any future vaccinations, though vaccines without aluminum should be preferentially selected when possible.

AB - Reports detailing the acute formation of aluminum granulomas, which can cause persistent, intensely pruritic nodules secondary to the administration of aluminum-containing vaccines, are infrequently described in medical literature. To our knowledge, this is the first report describing the development of an aluminum granuloma causing a persistent, pruritic nodule at the injection site following the administration of the DTaP-IPV vaccine. We present the case of a 6-year-old girl who developed a severely pruritic subcutaneous nodule on her anterior right thigh at the injection site three weeks after the administration of the aluminum-containing DTaP-IPV (Kinrix) vaccine. The nodule was eventually excised 14 months after its initial appearance, after which her symptoms resolved. Histologic inspection demonstrated a dense, deep dermal and subcutaneous nodular mixed infiltrate of lymphocytes, histiocytes, and eosinophils, with germinal center formation. The bluish, amphophilic granular cytoplasm found in most of the histiocytes is a characteristic feature of “aluminum granulomas.” This adverse reaction should be considered in any patient presenting with similar findings in the weeks following a DTaP-IPV vaccination or other aluminum-containing vaccines. Furthermore, the self-limiting tendency of these nodules should not preclude affected patients from any future vaccinations, though vaccines without aluminum should be preferentially selected when possible.

KW - aluminum granuloma

KW - dermatopathology

KW - pediatric dermatology

KW - subcutaneous nodule

KW - vaccine site reactions

KW - vaccines

UR - http://www.scopus.com/inward/record.url?scp=85057862652&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057862652&partnerID=8YFLogxK

U2 - 10.1111/pde.13732

DO - 10.1111/pde.13732

M3 - Article

C2 - 30488642

AN - SCOPUS:85057862652

JO - Pediatric Dermatology

JF - Pediatric Dermatology

SN - 0736-8046

ER -